Statistics

Total Visits

Views
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer 349

Total Visits per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer 9 1 7 4 2 9 9

File Downloads

Views
hdl_136580.pdf 173

Top Country Views

Views
Australia 240
United States 35
Poland 18
Vietnam 9
Ireland 8
Belgium 5
China 5
Hong Kong SAR China 4
Singapore 3
Argentina 2

Top City Views

Views
Gdansk 18
Ashburn 10
Hanoi 9
Dublin 7
Sydney 7
Boardman 5
Brussels 5
Arezzo 2
London 2
Singapore 2